Terns Pharmaceuticals, Inc. (TERN) - Quarterly Income Statement

Home
TERN
Financials

4.66 (USD) • At close February 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4
Revenue Numbers are in millions	0	0	0	1.322	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.24	0.236	0.22	0.222	0.217	0.222	0.485	0.252	0.269	0.278	0.114	0.107	0.119	0.172	0	0	0	0	0
Gross Profit Numbers are in millions	0	-0.24	-0.236	1.102	-0.222	-0.217	-0.222	-0.485	-0.252	-0.269	-0.278	0.886	-0.107	-0.119	-0.172	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0.834	0	0	0	0	0	0	0	0.886	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	15.169	18.352	18.587	17.459	14.831	14.151	17.056	10.658	12.161	8.662	8.136	9.462	7.153	5.961	8.735	7.77	5.404	7.611	7.244	7.556
General & Administrative Expenses Numbers are in millions	9.77	7.185	6.859	6.599	18.353	7.008	7.101	6.17	5.131	5.422	5.689	5.416	4.715	4.857	4.561	0.998	3.333	2.486	2.179	2.388
Selling & Marketing Expenses Numbers are in millions	0	0	-0.236	-0.22	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	9.77	7.185	6.623	6.379	18.353	7.008	7.101	6.17	5.131	5.422	5.689	5.416	4.715	4.857	4.561	0.998	3.333	2.486	2.179	2.388
Other Expenses Numbers are in millions	0	0	-0.012	-0.245	-0.005	-0.06	-0.004	-0.004	-0.014	-0.054	0.004	0.01	0.004	0.039	-0.013	-0.747	-2.753	0.25	0.167	0.139
Operating Expenses Numbers are in millions	24.939	25.537	25.21	23.838	33.184	21.159	24.157	16.828	17.292	14.084	13.825	14.878	11.868	10.818	13.296	8.768	8.737	10.097	9.423	9.944
Operating Income Numbers are in millions	-24.939	-25.537	-25.446	-24.058	-33.184	-21.159	-24.157	-16.828	-17.292	-14.084	-13.825	-13.878	-11.868	-10.818	-13.296	-8.768	-8.737	-10.097	-9.423	-9.944
Operating Income Ratio Numbers are in millions	0	0	0	-18.198	0	0	0	0	0	0	0	-13.878	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.056	2.862	3.17	3.088	3.475	3.335	2.689	1.324	0.485	0.16	0.073	0.065	0.053	0.094	-0.002	-0.45	-2.752	0.252	0.217	-0.1
Income Before Tax Numbers are in millions	-21.883	-22.675	-22.276	-20.97	-29.709	-17.824	-21.468	-15.504	-16.807	-13.924	-13.752	-13.813	-11.815	-10.724	-13.298	-9.218	-11.489	-9.845	-9.206	-10.044
Income Before Tax Ratio Numbers are in millions	0	0	0	-15.862	0	0	0	0	0	0	0	-13.813	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0.062	0.061	0.097	0.049	0.058	0.072	0.06	0.318	0.013	0.006	0.021	0.435	0.02	0.014	0.039	0.711	0.102	-0.159	-0.255	0.002
Net Income Numbers are in millions	-21.945	-22.736	-22.373	-21.019	-29.767	-17.896	-21.528	-15.822	-16.82	-13.93	-13.773	-14.248	-11.835	-10.738	-13.337	-9.929	-11.435	-9.688	-9.001	-9.775
Net Income Ratio Numbers are in millions	0	0	0	-15.899	0	0	0	0	0	0	0	-14.248	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.28	-0.31	-0.3	-0.29	-0.42	-0.25	-0.31	-0.29	-0.44	-0.55	-0.55	-0.56	-0.47	-0.43	-0.88	-0.65	-0.48	-0.4	-0.38	-0.41
EPS Diluted Numbers are in millions	-0.28	-0.31	-0.3	-0.29	-0.42	-0.25	-0.31	-0.29	-0.44	-0.55	-0.55	-0.56	-0.47	-0.43	-0.88	-0.65	-0.48	-0.4	-0.38	-0.41
EBITDA Numbers are in millions	-24.733	-25.297	-25.364	-23.986	-33.112	-21.159	-24.157	-16.586	-17.04	-13.815	-13.474	-13.764	-11.761	-10.699	-13.124	-8.662	-8.636	-9.998	-9.335	-9.625
EBITDA Ratio Numbers are in millions	0	0	0	-18.032	0	0	0	0	0	0	0	-13.878	0	0	0	0	0	0	0	0

Terns Pharmaceuticals, Inc.

NASDAQ:TERN Add to watchlist

NASDAQ:TERN